Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Immunity ; 56(6): 1410-1428.e8, 2023 06 13.
Article in English | MEDLINE | ID: covidwho-20244437

ABSTRACT

Although host responses to the ancestral SARS-CoV-2 strain are well described, those to the new Omicron variants are less resolved. We profiled the clinical phenomes, transcriptomes, proteomes, metabolomes, and immune repertoires of >1,000 blood cell or plasma specimens from SARS-CoV-2 Omicron patients. Using in-depth integrated multi-omics, we dissected the host response dynamics during multiple disease phases to reveal the molecular and cellular landscapes in the blood. Specifically, we detected enhanced interferon-mediated antiviral signatures of platelets in Omicron-infected patients, and platelets preferentially formed widespread aggregates with leukocytes to modulate immune cell functions. In addition, patients who were re-tested positive for viral RNA showed marked reductions in B cell receptor clones, antibody generation, and neutralizing capacity against Omicron. Finally, we developed a machine learning model that accurately predicted the probability of re-positivity in Omicron patients. Our study may inspire a paradigm shift in studying systemic diseases and emerging public health concerns.


Subject(s)
Blood Platelets , COVID-19 , Humans , SARS-CoV-2 , Breakthrough Infections , Multiomics , Antibodies, Neutralizing , Antibodies, Viral
2.
Front Med (Lausanne) ; 10: 1132630, 2023.
Article in English | MEDLINE | ID: covidwho-2320538

ABSTRACT

The manifestation of severe pneumonia is only occasional, and pneumomediastinum is a condition that occurs rarely in Coronavirus disease 2019 (COVID-19) patients, especially in those patients who are infected with the Omicron variant. In addition, whether severe pneumonia or pneumomediastinum often occurs in patients in older age, in poor physical condition, or with underlying diseases remains to be ascertained. To date, severe pneumonia and pneumomediastinum due to Omicron infection had not been reported in a young patient with an excellent physical condition. In this study, we report such a case with the aforementioned manifestations in a robust adolescent infected with Omicron BA.5.2.

3.
Emerg Microbes Infect ; 12(1): 2202263, 2023 Dec.
Article in English | MEDLINE | ID: covidwho-2295932

ABSTRACT

The adaptive immunity against SARS-CoV-2 prototype strain and Omicron sublineages induced by BA.1 breakthrough infection in vaccinees of inactivated COVID-19 vaccines have not been well characterized. Here, we report that BA.1 breakthrough infection induced mucosal sIgA and resulted in higher IgG titers against prototype strain and Omicron sublineages in vaccinees than in vaccine naïve-infected individuals. BA.1 breakthrough infection boosted antibody-dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis to prototype strain and BA.1, BA.1.1, BA.2, BA.2.12.1, and BA.2.75 but not BA.4/5 and induced neutralization against prototype strain and BA.1, BA.1.1, BA.2, BA.2.12.1, BA.2.75, and BA.4/5 but not BF.7, BQ.1, and XBB. In total, BA.1 breakthrough infection individuals produced less extensive sIgA, plasma IgG and NAb responses against Omicron sublineages compared with those against prototype strain. Further, BA.1 breakthrough infection induced recall B cell response to prototype strain and Omicron variant, primarily targeting memory B cells producing conserved epitopes. Memory T cell responses against Omicron is largely preserved. Individuals with vaccine booster did not induce more beneficial immune responses to Omicron sublineages upon BA.1 breakthrough infection than those with primary vaccine dose only. The breakthrough infection individuals produced stronger adaptive immunity than those of inactivated vaccine-healthy individuals. These data have important implications for understanding the vaccine effectiveness and adaptive immunity to breakthrough infection in individuals fully immunized with inactivated vaccines. Omicron sublineages, especially for those emerged after BA.4/5 strain, evade NAb responses induced by BA.1 breakthrough infection. It is urgent to optimize the vaccine immunogen design and formulations to SARS-CoV-2 variants.


Subject(s)
COVID-19 Vaccines , COVID-19 , Humans , Breakthrough Infections , SARS-CoV-2 , T-Lymphocytes , Immunoglobulin A, Secretory , Immunoglobulin G , Antibodies, Viral , Antibodies, Neutralizing
4.
JMIR Public Health Surveill ; 9: e38072, 2023 03 08.
Article in English | MEDLINE | ID: covidwho-2274127

ABSTRACT

BACKGROUND: Evidence suggests that individuals may change adherence to public health policies aimed at reducing the contact, transmission, and spread of the SARS-CoV-2 virus after they receive their first SARS-CoV-2 vaccination when they are not fully vaccinated. OBJECTIVE: We aimed to estimate changes in median daily travel distance of our cohort from their registered addresses before and after receiving a SARS-CoV-2 vaccine. METHODS: Participants were recruited into Virus Watch starting in June 2020. Weekly surveys were sent out to participants, and vaccination status was collected from January 2021 onward. Between September 2020 and February 2021, we invited 13,120 adult Virus Watch participants to contribute toward our tracker subcohort, which uses the GPS via a smartphone app to collect data on movement. We used segmented linear regression to estimate the median daily travel distance before and after the first self-reported SARS-CoV-2 vaccine dose. RESULTS: We analyzed the daily travel distance of 249 vaccinated adults. From 157 days prior to vaccination until the day before vaccination, the median daily travel distance was 9.05 (IQR 8.06-10.09) km. From the day of vaccination to 105 days after vaccination, the median daily travel distance was 10.08 (IQR 8.60-12.42) km. From 157 days prior to vaccination until the vaccination date, there was a daily median decrease in mobility of 40.09 m (95% CI -50.08 to -31.10; P<.001). After vaccination, there was a median daily increase in movement of 60.60 m (95% CI 20.90-100; P<.001). Restricting the analysis to the third national lockdown (January 4, 2021, to April 5, 2021), we found a median daily movement increase of 18.30 m (95% CI -19.20 to 55.80; P=.57) in the 30 days prior to vaccination and a median daily movement increase of 9.36 m (95% CI 38.6-149.00; P=.69) in the 30 days after vaccination. CONCLUSIONS: Our study demonstrates the feasibility of collecting high-volume geolocation data as part of research projects and the utility of these data for understanding public health issues. Our various analyses produced results that ranged from no change in movement after vaccination (during the third national lock down) to an increase in movement after vaccination (considering all periods, up to 105 days after vaccination), suggesting that, among Virus Watch participants, any changes in movement distances after vaccination are small. Our findings may be attributable to public health measures in place at the time such as movement restrictions and home working that applied to the Virus Watch cohort participants during the study period.


Subject(s)
COVID-19 Vaccines , COVID-19 , Adult , Humans , Wales , SARS-CoV-2 , Cohort Studies , Geographic Information Systems , COVID-19/epidemiology , COVID-19/prevention & control , Communicable Disease Control , England , Vaccination , Self Report
5.
PLoS One ; 18(1): e0277913, 2023.
Article in English | MEDLINE | ID: covidwho-2214774

ABSTRACT

Exploration of dynamic human activity gives significant insights into understanding the urban environment and can help to reinforce scientific urban management strategies. Lots of studies are arising regarding the significant human activity changes in global metropolises and regions affected by COVID-19 containment policies. However, the variations of human activity dynamics amid different phases divided by the non-pharmaceutical intervention policies (e.g., stay-at-home, lockdown) have not been investigated across urban areas in space and time and discussed with the urban characteristic determinants. In this study, we aim to explore the influence of different restriction phases on dynamic human activity through sensing human activity zones (HAZs) and their dominated urban characteristics. Herein, we proposed an explainable analysis framework to explore the HAZ variations consisting of three parts, i.e., footfall detection, HAZs delineation and the identification of relationships between urban characteristics and HAZs. In our study area of Greater London, United Kingdom, we first utilised the footfall detection method to extract human activity metrics (footfalls) counted by visits/stays at space and time from the anonymous mobile phone GPS trajectories. Then, we characterised HAZs based on the homogeneity of daily human footfalls at census output areas (OAs) during the predefined restriction phases in the UK. Lastly, we examined the feature importance of explanatory variables as the metric of the relationship between human activity and urban characteristics using machine learning classifiers. The results show that dynamic human activity exhibits statistically significant differences in terms of the HAZ distributions across restriction phases and is strongly associated with urban characteristics (e.g., specific land use types) during the COVID-19 pandemic. These findings can improve the understanding of the variation of human activity patterns during the pandemic and offer insights into city management resource allocation in urban areas concerning dynamic human activity.


Subject(s)
COVID-19 , Pandemics , Humans , London/epidemiology , Big Data , Communicable Disease Control , COVID-19/epidemiology , Human Activities
6.
BMJ Open ; 12(12): e066359, 2022 12 15.
Article in English | MEDLINE | ID: covidwho-2161862

ABSTRACT

OBJECTIVE: To report how the Chinese mainland battled its first omicron wave, which happened in Tianjin, a metropolis with 14 million residents. We also sought to better understand how clinical features affected the timing of viral clearance. DESIGN: A retrospective study of the omicron wave in Tianjin between 8 January 2022 and 3 March 2022. SETTING: Except for the first cases on 8 January, all the omicron cases were identified through PCR mass testing in the residential communities. Residential quarantine and serial PCR mass testing were dynamically adjusted according to the trends of new cases. PARTICIPANTS: All the 417 consecutive PCR-positive cases identified through mass screening of the entire city's 14 million residents. 45.3% of the cases were male, and the median age was 37 (range 0.3-90). 389 (93%) cases had complete data for analysing the correlation between clinical features and the timing of viral clearance. MAIN OUTCOME AND MEASURE: Time to viral clearance. RESULTS: Tianjin initiated the 'dynamic zero-COVID' policy very early, that is, when daily new case number was ≈0.4 cases per 1 000 000 residents. Daily new cases dropped to <5 after 3 February, and the number of affected residential subdivisions dropped to ≤2 after 13 February. 64% (267/417) of the cases had no or mild symptoms. The median interval from hospital admission to viral clearance was 10 days (range 3-28). An exploratory analysis identified a feature cluster associated with earlier viral clearance, with HRs of 3.56 (95% CI 1.66 to 7.63) and 3.15 (95% CI 1.68 to 5.91) in the training and validation sets, respectively. CONCLUSIONS: The 'dynamic zero-COVID' policy can suppress an omicron wave within a month. It might be possible to predict in advance which cases will require shorter periods of isolation based on their clinical features.


Subject(s)
COVID-19 , Humans , Male , Adult , Female , Retrospective Studies , COVID-19/epidemiology , Policy , China/epidemiology , Asian People
7.
JGH Open ; 6(12): 869-875, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2115584

ABSTRACT

Background and Aim: During COVID-19, restrictions to elective endoscopy were introduced worldwide. A reduction in procedures may impact trainees' endoscopy learning. This study aims to assess Australian advanced gastroenterology and general surgery trainees' self-perceived efficacy and knowledge in endoscopy during the pandemic. Methods: All Australian gastroenterology and general surgery trainees in their last 2 years of accredited training were invited to participate through email (2020-2021 and 2021-2022 training cycles). The primary outcome was to assess trainees' self-efficacy and knowledge regarding gastrointestinal endoscopy. Secondary outcomes included subgroup analysis between gastroenterology and general surgery trainees. Self-perceived efficacy was assessed with Likert-scale questions on 20 endoscopy procedures and knowledge was assessed through 21 endoscopy-related multiple choice questions. Results: Eighty-one trainees responded to a self-efficacy questionnaire and 77 responded to the knowledge questionnaire. Over 90% of the trainees were confident or extremely confident in diagnostic endoscopy, but only half demonstrated similar efficacy for therapeutic endoscopy. The efficacy for basic endoscopy procedures was higher for gastroenterology trainees (64.0% vs 51.1%, P < 0.001). Last-year trainee achievement of conjoint committee requirements for upper gastrointestinal endoscopy was achieved in 95.8% of gastroenterology trainees versus 22.2% of surgical trainees (P < 0.001). The median score on the knowledge questionnaire was also higher for the gastroenterology subset (90.5% vs 71.4%, P < 0.001). Conclusion: During COVID-19, endoscopy trainees' self-efficacy in endoscopic diagnostic procedures was achieved for most trainees. The differences in self-perceived efficacy and knowledge between gastroenterology and surgical trainees may be reflective of the different opportunities for learning between the two groups.

8.
Frontiers in public health ; 10, 2022.
Article in English | EuropePMC | ID: covidwho-2092312

ABSTRACT

Objective Since the outbreak of COVID-19, public health and social measures to contain its transmission (e.g., social distancing and lockdowns) have dramatically changed people's lives in rural and urban areas globally. To facilitate future management of the pandemic, it is important to understand how different socio-demographic groups adhere to such demands. This study aims to evaluate the influences of restriction policies on human mobility variations associated with socio-demographic groups in England, UK. Methods Using mobile phone global positioning system (GPS) trajectory data, we measured variations in human mobility across socio-demographic groups during different restriction periods from Oct 14, 2020 to Sep 15, 2021. The six restriction periods which varied in degree of mobility restriction policies, denoted as “Three-tier Restriction,” “Second National Lockdown,” “Four-tier Restriction,” “Third National Lockdown,” “Steps out of Lockdown,” and “Post-restriction,” respectively. Individual human mobility was measured with respect to the time period people stayed at home, visited places outside the home, and traveled long distances. We compared these indicators across the six restriction periods and across socio-demographic groups. Results All human mobility indicators significantly differed across the six restriction periods, and the influences of restriction policies on individual mobility behaviors are correlated with socio-demographic groups. In particular, influences relating to mobility behaviors are stronger in younger and low-income groups in the second and third national lockdowns. Conclusions This study enhances our understanding of the influences of COVID-19 pandemic restriction policies on human mobility behaviors within different social groups in England. The findings can be usefully extended to support policy-making by investigating human mobility and differences in policy effects across not only age and income groups, but also across geographical regions.

9.
Geo-spatial Information Science ; : 1-13, 2022.
Article in English | Taylor & Francis | ID: covidwho-2082339
10.
Comput Urban Sci ; 2(1): 13, 2022.
Article in English | MEDLINE | ID: covidwho-1943897

ABSTRACT

Crime changes have been reported as a result of human routine activity shifting due to containment policies, such as stay-at-home (SAH) mandates during the COVID-19 pandemic. However, the way in which the manifestation of crime in both space and time is affected by dynamic human activities has not been explored in depth in empirical studies. Here, we aim to quantitatively measure the spatio-temporal stratified associations between crime patterns and human activities in the context of an unstable period of the ever-changing socio-demographic backcloth. We propose an analytical framework to detect the stratified associations between dynamic human activities and crimes in urban areas. In a case study of San Francisco, United States, we first identify human activity zones (HAZs) based on the similarity of daily footfall signatures on census block groups (CBGs). Then, we examine the spatial associations between crime spatial distributions at the CBG-level and the HAZs using spatial stratified heterogeneity statistical measurements. Thirdly, we use different temporal observation scales around the effective date of the SAH mandate during the COVID-19 pandemic to investigate the dynamic nature of the associations. The results reveal that the spatial patterns of most crime types are statistically significantly associated with that of human activities zones. Property crime exhibits a higher stratified association than violent crime across all temporal scales. Further, the strongest association is obtained with the eight-week time span centred around the SAH order. These findings not only enhance our understanding of the relationships between urban crime and human activities, but also offer insights into that tailored crime intervention strategies need to consider human activity variables.

11.
Front Pharmacol ; 12: 765553, 2021.
Article in English | MEDLINE | ID: covidwho-1785387

ABSTRACT

COVID-19 is threatening human health worldwide but no effective treatment currently exists for this disease. Current therapeutic strategies focus on the inhibition of viral replication or using anti-inflammatory/immunomodulatory compounds to improve host immunity, but not both. Traditional Chinese medicine (TCM) compounds could be promising candidates due to their safety and minimal toxicity. In this study, we have developed a novel in silico bioinformatics workflow that integrates multiple databases to predict the use of honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) as potential anti-SARS-CoV-2 agents. Using extracts from honeysuckle and Huangqi, these two herbs upregulated a group of microRNAs including let-7a, miR-148b, and miR-146a, which are critical to reduce the pathogenesis of SARS-CoV-2. Moreover, these herbs suppressed pro-inflammatory cytokines including IL-6 or TNF-α, which were both identified in the cytokine storm of acute respiratory distress syndrome, a major cause of COVID-19 death. Furthermore, both herbs partially inhibited the fusion of SARS-CoV-2 spike protein-transfected BHK-21 cells with the human lung cancer cell line Calu-3 that was expressing ACE2 receptors. These herbs inhibited SARS-CoV-2 Mpro activity, thereby alleviating viral entry as well as replication. In conclusion, our findings demonstrate that honeysuckle and Huangqi have the potential to be used as an inhibitor of SARS-CoV-2 virus entry that warrants further in vivo analysis and functional assessment of miRNAs to confirm their clinical importance. This fast-screening platform can also be applied to other drug discovery studies for other infectious diseases.

12.
NPJ Climate and Atmospheric Science ; 5(1), 2022.
Article in English | ProQuest Central | ID: covidwho-1764207

ABSTRACT

With improving PM2.5 air quality, the tropospheric ozone (O3) has become the top issue of China’s air pollution control. Here, we combine comprehensive observational data analysis with models to unveil the contributions of different processes and precursors to the change of O3 during COVID-19 lockdown in the Yangtze River Delta (YRD), one of the most urbanized megacity regions of eastern China. Despite a 44 to 47% reduction in volatile organic compounds (VOCs) and nitrogen oxides (NOx) emissions, maximum daily 8-h average (MDA8) ozone concentrations increase from 28 ppbv in pre-lockdown to 43 ppbv in lockdown period. We reproduce this transition with the WRF-Chem model, which shows that ~80% of the increase in MDA8 is due to meteorological factors (seasonal variation and radiation), and ~20% is due to emission reduction. We find that daytime photochemistry does not lead to an increase but rather a decrease of daytime O3 production during the lockdown. However, the reduced O3 production is overwhelmed by the weakened nitric oxide (NO) titration resulting in a net increase of O3 concentration. Although the emission reduction increases O3 concentration, it leads to a decrease in the Ox (O3 + NO2) concentration, suggesting reduced atmospheric oxidation capacity on a regional scale. The dominant effect of NO titration demonstrates the importance of prioritizing VOCs reduction, especially from solvent usage and the petrochemical industry with high emission ratios of VOCs/NOx.

13.
Prim Health Care Res Dev ; 23: e4, 2022 01 28.
Article in English | MEDLINE | ID: covidwho-1655381

ABSTRACT

BACKGROUND: With the global spreading of Coronavirus disease (COVID-19), many primary care medical workers have been infected, particularly in the early stages of this pandemic. Although extensive studies have explored the COVID-19 transmission patterns and (non-) pharmaceutical intervention to protect the general public, limited research has analysed the measures to prevent nosocomial transmission based upon detailed interpersonal contacts between medical staff and patients. AIM: This paper aims to develop and evaluate proactive prevention measures to contain the nosocomial transmission of COVID-19. The specific objectives are (1) to understand the virus transmission via interpersonal contacts among medical staff and patients; (2) to define proactive measures to reduce the risk of infection of medical staff and (3) evaluate the effectiveness of these measures to control the COVID-19 epidemic in hospitals. METHODS: We observed the operation of a typical primary hospital in China to understand the interpersonal contacts among medical staff and patients. We defined effective distance as the indicator for risk of transmission. Then three proactive measures were proposed based upon the observations, including a medical staff rotation system, the establishment of a separate fever clinic and medical staff working alone. Finally, the impacts of these measures are evaluated with a modified Susceptible-Exposure-Infected-Removed model accommodating the situation of hospitals and asymptomatic and latent infection of COVID-19. The case study was conducted with the hospital observed in December 2019 and February 2020. FINDINGS: The implementation of the medical staff rotation system has the most significant impact on containing the epidemic. The establishment of a separate fever clinic and medical staff working alone also benefits from inhibiting the epidemic outbreak. The simulation finds that if effective prevention and control measures are not taken in time, it will lead to a surge of infection cases in all asymptomatic probabilities and incubation periods.


Subject(s)
COVID-19 , Cross Infection , Cross Infection/prevention & control , Health Personnel , Humans , Pandemics , SARS-CoV-2
15.
Chin Med ; 16(1): 130, 2021 Dec 03.
Article in English | MEDLINE | ID: covidwho-1551216

ABSTRACT

The Coronavirus disease 2019 (COVID-19) pandemic is still spread and has made a severe public health threat around the world. To improve disease progression, emerging Chinese herbal compounds were used in clinical practice and some agents have proven beneficial in treating COVID-19. Here, the relevant literature from basic researches to clinical application were identified and comprehensively assessed. A variety of Chinese herbal compounds have been reported to be effective in improving symptoms and outcomes in patients with COVID-19, particularly together with routine treatment strategy. The pharmacological activities were mainly attributed to the relief of clinical symptoms, inhibition of cytokine storm, and improvement of organ function. Besides, the development of novel antiviral drugs from medicinal herbs were further discussed. The updated laboratory and clinical studies provided the evidence of Chinese herbal compounds such as Lianhua Qingwen prescription, Shufeng Jiedu prescription, and Qingfei Paidu Tang for the relief of COVID-19. However, both of the randomized controlled trials and real world researches need to be done for supporting the evidence including the efficacy and safety in fighting COVID-19.

16.
Cell Discov ; 7(1): 60, 2021 Aug 04.
Article in English | MEDLINE | ID: covidwho-1541177

ABSTRACT

Severe coronavirus disease 2019 (COVID-19) is often indicated by lymphopenia and increased myelopoiesis; however, the underlying mechanism is still unclear, especially the alteration of hematopoiesis. It is important to explore to what extent and how hematopoietic stem cells contribute to the impairment of peripheral lymphoid and myeloid compartments in COVID-19 patients. In this study, we used single-cell RNA sequencing to assess bone marrow mononuclear cells from COVID-19 patients with peripheral blood mononuclear cells as control. The results showed that the hematopoietic stem cells in these patients were mainly in the G1 phase and prone to apoptosis, with immune activation and anti-viral responses. Importantly, a significant accumulation of immature myeloid progenitors and a dramatic reduction of lymphoid progenitors in severe cases were identified, along with the up-regulation of transcription factors (such as SPI1, LMO4, ETS2, FLI1, and GATA2) that are important for the hematopoietic stem cell or multipotent progenitor to differentiate into downstream progenitors. Our results indicate a dysregulated hematopoiesis in patients with severe COVID-19.

17.
BMJ Open ; 11(6): e048042, 2021 06 23.
Article in English | MEDLINE | ID: covidwho-1285085

ABSTRACT

INTRODUCTION: The coronavirus (COVID-19) pandemic has caused significant global mortality and impacted lives around the world. Virus Watch aims to provide evidence on which public health approaches are most likely to be effective in reducing transmission and impact of the virus, and will investigate community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviours. METHODS AND ANALYSIS: Virus Watch is a household community cohort study of acute respiratory infections in England and Wales and will run from June 2020 to August 2021. The study aims to recruit 50 000 people, including 12 500 from minority ethnic backgrounds, for an online survey cohort and monthly antibody testing using home fingerprick test kits. Nested within this larger study will be a subcohort of 10 000 individuals, including 3000 people from minority ethnic backgrounds. This cohort of 10 000 people will have full blood serology taken between October 2020 and January 2021 and repeat serology between May 2021 and August 2021. Participants will also post self-administered nasal swabs for PCR assays of SARS-CoV-2 and will follow one of three different PCR testing schedules based on symptoms. ETHICS AND DISSEMINATION: This study has been approved by the Hampstead National Health Service (NHS) Health Research Authority Ethics Committee (ethics approval number 20/HRA/2320). We are monitoring participant queries and using these to refine methodology where necessary, and are providing summaries and policy briefings of our preliminary findings to inform public health action by working through our partnerships with our study advisory group, Public Health England, NHS and government scientific advisory panels.


Subject(s)
COVID-19 , Guideline Adherence/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Public Health , COVID-19/epidemiology , England/epidemiology , Humans , Prospective Studies , Risk Factors , State Medicine , Wales/epidemiology
18.
Comput Urban Sci ; 1(1): 9, 2021.
Article in English | MEDLINE | ID: covidwho-1252338

ABSTRACT

Gauging viral transmission through human mobility in order to contain the COVID-19 pandemic has been a hot topic in academic studies and evidence-based policy-making. Although it is widely accepted that there is a strong positive correlation between the transmission of the coronavirus and the mobility of the general public, there are limitations to existing studies on this topic. For example, using digital proxies of mobile devices/apps may only partially reflect the movement of individuals; using the mobility of the general public and not COVID-19 patients in particular, or only using places where patients were diagnosed to study the spread of the virus may not be accurate; existing studies have focused on either the regional or national spread of COVID-19, and not the spread at the city level; and there are no systematic approaches for understanding the stages of transmission to facilitate the policy-making to contain the spread. To address these issues, we have developed a new methodological framework for COVID-19 transmission analysis based upon individual patients' trajectory data. By using innovative space-time analytics, this framework reveals the spatiotemporal patterns of patients' mobility and the transmission stages of COVID-19 from Wuhan to the rest of China at finer spatial and temporal scales. It can improve our understanding of the interaction of mobility and transmission, identifying the risk of spreading in small and medium-sized cities that have been neglected in existing studies. This demonstrates the effectiveness of the proposed framework and its policy implications to contain the COVID-19 pandemic.

19.
JGH Open ; 5(5): 542-548, 2021 May.
Article in English | MEDLINE | ID: covidwho-1220272

ABSTRACT

BACKGROUND AND AIM: Telehealth has become the standard of care during the COVID-19 outbreak. This study aimed to assess doctor and patient satisfaction of endoscopy-related telehealth clinics with video consultations. METHODS: A prospective observational study of patients consecutively booked to attend two endoscopy-related telehealth clinics at an ambulatory tertiary care setting was conducted from July to October 2020. Data collected from our previously published study using phone consultations (data collected in April-May 2020) were used as a control arm. The primary outcome (satisfaction) was assessed through the six-question score (6Q_score) as per previous research. Secondary outcomes included failure-to-attend (FTA) rate and perceived necessity of physical examination/in-person follow-up appointment. RESULTS: There were 962 endoscopy clinic appointments between July and October, of which 157 were conducted through video. Data on 127 doctor questionnaires and 94 patient questionnaires were analyzed. The median age (years) of patients reviewed via video [57, interquartile range (IQR) 48-66] was lower than those reviewed via phone (65, IQR 55-74, P < 0.01). Patient average 6Q_score was higher with video compared to phone (85.1% vs 78.4%, P = 0.01), as was doctors' 6Q_score (97.5% vs 91.9%, P = 0.02). FTA rates remained similar between the two assessments (6.4% in April/May and 4.4% between July/October, P = 0.12). The requirement for in-person follow-up/physical examination was identified in two video consultations (1.6%). CONCLUSION: Video consultations during the COVID-19 outbreak demonstrated higher patient and doctor satisfaction compared to phone consultations. There was no significant difference in FTA rates and need for in-person follow-up consultations/physical examination between the telehealth two modalities.

20.
Journal of Gastroenterology and Hepatology (Australia) ; 35(SUPPL 1):201, 2020.
Article in English | EMBASE | ID: covidwho-1109579

ABSTRACT

Background and Aim: During the outbreak of coronavirus 2019 disease (COVID-19), major restrictions to in-person consultations were introduced. This led to a change in outpatient clinic delivery through the roll-out of telehealth appointments, with phone consultations being the most convenient modality. We postulated that an indirect benefit of phone consultations would be a better clinic attendance rate. This study aimed to assess if the “failure-to-attend” (FTA) rate for the two endoscopy-related clinics at our institution improved with phone consultations during the COVID-19 outbreak. Methods: Data from consecutive patients booked to attend any of the two weekly endoscopy-related clinics between 15 April and 27 May 2020 were prospectively assessed for the phone clinic cohort. For the in-person clinic cohort, attendance rates from both clinics held between 15 April and 29 May 2019 were retrospectively assessed. Based on observation of the first few endoscopy-related outpatient clinics held in March 2020 at our hospital, we anticipated an expected difference of 8% in FTA rate, leading to a calculated sample size of 150 patients (allowing for a 10% safety margin). The main outcome was the difference in FTA rates between the phone and in-person clinic cohorts. Secondary outcomes included subanalysis of the low-complexity (Post-Endoscopy) and high-complexity (Advanced Endoscopy) clinics and evaluation of patients' and doctors' satisfaction. Satisfaction was assessed based on questionnaires used in a previous study on telehealth consultations and mostly used the Likert scale (“strongly disagree” to “strongly agree”), where the closer the response was to “strongly agree,” the more satisfied the individual. Results: A total of 691 patients were booked for appointments in our endoscopy clinics during the study periods (318 in 2019 and 373 in 2020). The average age was similar between both cohorts (60.6 vs 61.9 years, P = 0.34), as was the proportion of male patients (43.4% vs 48.7%, P = 0.07). The average phone consultation duration was slightly longer for the Post-Endoscopy clinic (11 min vs 14 min, P < 0.01), which also had a higher proportion of first consultations with gastroenterology (22.2% vs 30.8%, P = 0.06). FTA rates were better for both clinics with the adoption of phone consultations (Table 1). The satisfaction profiles of patients and doctors are summarized in Figures 1 and 2, respectively. Although both describe high levels of satisfaction, the rate of agree/strongly agree was lower for patients (78.4% vs 91.9%, P < 0.01). The doctors' overall satisfaction (0-100%) score was high for both clinics but slightly higher for the Advanced Endoscopy clinic (97.6% vs 93.1%, P < 0.01). In only 3.5% of cases was a follow-up consultation suggested to be carried out in person. Conclusion: The use of phone consultations in endoscopy-related clinics during the COVID-19 outbreak has improved FTA rates in our institution while maintaining high satisfaction rates for both patients and doctors. The need for in-person follow-up consultations was low. These data suggest that employing telehealth for endoscopy-related clinics is a viable alternative that is cost-effective and a widely accepted modality of communication for both patients and clinicians.1.

SELECTION OF CITATIONS
SEARCH DETAIL